Published in Cancer on February 15, 2001
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut (2005) 3.86
Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis. Clin Gastroenterol Hepatol (2009) 2.72
Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas. Ann Rheum Dis (2005) 2.25
Cancer in inflammatory bowel disease. World J Gastroenterol (2008) 2.12
Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. Gastroenterology (2012) 1.97
Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer. Cancer Microenviron (2010) 1.96
Risks of myeloid malignancies in patients with autoimmune conditions. Br J Cancer (2009) 1.89
Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer. Nat Rev Gastroenterol Hepatol (2009) 1.80
Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J Gastroenterol (2008) 1.79
Epidemiology of cancer of the small intestine. World J Gastrointest Oncol (2011) 1.75
Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut (2005) 1.70
Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma. Clin Cancer Res (2009) 1.67
Review article: multiple myeloma and inflammatory bowel disease. Dig Dis Sci (2007) 1.64
Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Lab Invest (2008) 1.64
Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk? World J Gastroenterol (2012) 1.63
Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol Rev (2014) 1.57
miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis. Inflamm Bowel Dis (2015) 1.47
Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesis. J Clin Invest (2014) 1.46
VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancer. J Exp Med (2010) 1.45
Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front Immunol (2012) 1.44
Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol (2014) 1.44
Aberrant DNA Methylation: Implications in Racial Health Disparity. PLoS One (2016) 1.41
Colorectal cancer and dysplasia in inflammatory bowel disease. World J Gastroenterol (2008) 1.30
5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study. Gut (2005) 1.29
New targets for mucosal healing and therapy in inflammatory bowel diseases. Mucosal Immunol (2013) 1.25
Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans. Cancer (2010) 1.25
Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study. Gut (2005) 1.25
Colorectal cancer surveillance in inflammatory bowel disease: the search continues. World J Gastroenterol (2009) 1.24
Colon cancer and the immune system: the role of tumor invading T cells. World J Gastroenterol (2006) 1.24
Selective upregulation of microRNA expression in peripheral blood leukocytes in IL-10-/- mice precedes expression in the colon. J Immunol (2011) 1.23
Colitis-associated cancer: the role of T cells in tumor development. Semin Immunopathol (2009) 1.19
Defining quality indicators for best-practice management of inflammatory bowel disease in Canada. Can J Gastroenterol Hepatol (2014) 1.19
Inflammation and proliferation act together to mediate intestinal cell fusion. PLoS One (2009) 1.18
Crucial involvement of tumor-associated neutrophils in the regulation of chronic colitis-associated carcinogenesis in mice. PLoS One (2012) 1.17
Autophagy and Crohn's disease: at the crossroads of infection, inflammation, immunity, and cancer. Curr Mol Med (2010) 1.17
Mesalamine inhibits epithelial beta-catenin activation in chronic ulcerative colitis. Gastroenterology (2009) 1.15
Oral lichen planus as a preneoplastic inflammatory model. J Biomed Biotechnol (2012) 1.15
A prospective study of plasma inflammatory markers and risk of colorectal cancer in men. Br J Cancer (2013) 1.15
Development of fatal colitis in FVB mice infected with Citrobacter rodentium. Infect Immun (2007) 1.14
Acute myeloid leukemia developing in patients with autoimmune diseases. Haematologica (2011) 1.13
GUCY2C opposes systemic genotoxic tumorigenesis by regulating AKT-dependent intestinal barrier integrity. PLoS One (2012) 1.13
The role of mesalamine in the treatment of ulcerative colitis. Ther Clin Risk Manag (2007) 1.12
Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon. Inflamm Bowel Dis (2009) 1.10
The signatures of autozygosity among patients with colorectal cancer. Cancer Res (2008) 1.10
Health supervision in the management of children and adolescents with IBD: NASPGHAN recommendations. J Pediatr Gastroenterol Nutr (2012) 1.10
Host-microbial interactions and regulation of intestinal epithelial barrier function: From physiology to pathology. World J Gastrointest Pathophysiol (2012) 1.09
Intestinal inflammation and colorectal cancer: a double-edged sword? World J Gastroenterol (2011) 1.09
Differential microRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer. Hum Mutat (2012) 1.07
Opposing roles for IL-23 and IL-12 in maintaining occult cancer in an equilibrium state. Cancer Res (2012) 1.06
Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models. Mutat Res (2010) 1.06
Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of tumour necrosis factor-alpha antagonist therapy in Crohn's disease. Can J Gastroenterol (2009) 1.06
The 3020insC Allele of NOD2 Predisposes to Cancers of Multiple Organs. Hered Cancer Clin Pract (2005) 1.04
Oral treatment with genistein reduces the expression of molecular and biochemical markers of inflammation in a rat model of chronic TNBS-induced colitis. Eur J Nutr (2009) 1.04
mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice. J Clin Invest (2013) 1.03
MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice. Gastroenterology (2015) 1.01
The dual role of inflammation in colon carcinogenesis. Int J Mol Sci (2012) 1.01
A prospective study of macrophage inhibitory cytokine-1 (MIC-1/GDF15) and risk of colorectal cancer. J Natl Cancer Inst (2014) 1.00
Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study. Ann Rheum Dis (2014) 1.00
Colorectal cancer risk in Crohn's disease. World J Gastroenterol (2008) 0.99
Pathobiology of the neutrophil-intestinal epithelial cell interaction: role in carcinogenesis. World J Gastroenterol (2010) 0.99
Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn's disease patients: the Florence IBD study 1978-2001. Gut (2004) 0.98
MicroRNA-224 negatively regulates p21 expression during late neoplastic progression in inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.97
Ulcerative colitis-associated colorectal cancer. World J Gastroenterol (2014) 0.97
Adherence to guidelines for surveillance colonoscopy in patients with ulcerative colitis at a Canadian quaternary care hospital. Can J Gastroenterol (2009) 0.97
Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease. Gut (2004) 0.97
Is there truly a risk of lymphoma from biologic therapies? Dermatol Ther (2009) 0.96
Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences. Int J Colorectal Dis (2011) 0.95
Cancer risk in immune-mediated inflammatory diseases (IMID). Mol Cancer (2013) 0.95
Src as the link between inflammation and cancer. Front Physiol (2014) 0.95
Colorectal cancer in inflammatory bowel disease. Gut Liver (2008) 0.94
Colorectal cancer screening: Time for action in Iran. World J Gastrointest Oncol (2012) 0.94
Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells. Mucosal Immunol (2013) 0.93
Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer. Am J Physiol Gastrointest Liver Physiol (2011) 0.93
p53 mutations are associated with dysplasia and progression of dysplasia in patients with Crohn's disease. Dig Dis Sci (2007) 0.93
Detection of species-specific helicobacter ribosomal DNA in intestinal biopsy samples from a population-based cohort of patients with ulcerative colitis. J Clin Microbiol (2004) 0.93
Anaplastic large cell lymphoma of the colon in a patient with colonic Crohn disease treated with infliximab and methotrexate. Can J Gastroenterol Hepatol (2014) 0.92
Hospitalization-based major comorbidity of inflammatory bowel disease in Canada. Can J Gastroenterol (2007) 0.92
Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease. Therap Adv Gastroenterol (2011) 0.92
Immune effector cells produce lethal DNA damage in cells treated with a thiopurine. Cancer Res (2009) 0.91
Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease. J Crohns Colitis (2014) 0.91
PI3K/AKT signaling is essential for communication between tissue-infiltrating mast cells, macrophages, and epithelial cells in colitis-induced cancer. Clin Cancer Res (2013) 0.91
Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer. Autophagy (2014) 0.91
Innate inflammation and cancer: Is it time for cancer prevention? F1000 Med Rep (2011) 0.90
Small bowel adenocarcinoma in Crohn's disease: a case report and review of literature. World J Gastroenterol (2006) 0.90
Surveillance of dysplasia in inflammatory bowel disease: The gastroenterologist-pathologist partnership. Clin Gastroenterol Hepatol (2006) 0.90
Intestinal cancer in inflammatory bowel disease: natural history and surveillance guidelines. Ann Gastroenterol (2012) 0.90
Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes. Leukemia (2015) 0.90
Cysteinyl leukotrienes and their receptors: bridging inflammation and colorectal cancer. World J Gastroenterol (2014) 0.90
Differential effects of NOD2 polymorphisms on colorectal cancer risk: a meta-analysis. Int J Colorectal Dis (2009) 0.89
The impact of ulcerative colitis on patients' lives compared to other chronic diseases: a patient survey. Dig Dis Sci (2009) 0.89
Colorectal cancer screening among primary care patients: does risk affect screening behavior? J Community Health (2011) 0.89
CysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancer. PLoS One (2013) 0.89
Intestinal cancer in patients with Crohn's disease. Int J Colorectal Dis (2006) 0.88
Update on inflammatory bowel disease in patients with primary sclerosing cholangitis. World J Hepatol (2014) 0.88
Thiopurines in inflammatory bowel disease revisited. World J Gastroenterol (2013) 0.88
Has the risk of colorectal cancer in inflammatory bowel disease decreased? World J Gastroenterol (2013) 0.88
Role of TH17 cytokines in the control of colorectal cancer. Oncoimmunology (2013) 0.87
Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah. Dig Dis Sci (2017) 0.87
Hepatobiliary manifestations of ulcerative colitis: an example of gut-liver crosstalk. Gastroenterol Rep (Oxf) (2014) 0.87
Development of hepatocellular carcinoma in a patient with Crohn's disease treated with azathioprine. Dig Dis Sci (2007) 0.87
Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol (1999) 3.34
Record linkage strategies. Part I: Estimating information and evaluating approaches. Methods Inf Med (1991) 2.56
Assessing data quality: a computerized approach. Soc Sci Med (1989) 2.51
The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med (2000) 2.37
The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol (2001) 2.33
The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost (2001) 2.31
Incidence and prevalence of diabetes in Manitoba, 1986-1991. Diabetes Care (1996) 2.30
Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital. Am J Gastroenterol (2000) 2.01
Geographic analysis of diabetes prevalence in an urban area. Soc Sci Med (2003) 1.96
The role of collectives in STI and HIV/AIDS prevention among female sex workers in Karnataka, India. AIDS Care (2006) 1.87
Clinical effectiveness of influenza vaccination in Manitoba. JAMA (1993) 1.78
The art and science of record linkage: methods that work with few identifiers. Comput Biol Med (1986) 1.52
Therapeutic value of a gastroenterology consultation in irritable bowel syndrome. Aliment Pharmacol Ther (2003) 1.49
Variations in physicians' hospitalization practices: a population-based study in Manitoba, Canada. Am J Public Health (1986) 1.49
Generational differences in the age at diagnosis with Ibd: genetic anticipation, bias, or temporal effects. Am J Gastroenterol (2002) 1.46
Development of an assay for antibodies to Saccharomyces cerevisiae: Easy, cheap and specific for Crohn's disease. Can J Gastroenterol (2001) 1.46
Geographical variations in the epidemiology of bacterial sexually transmitted infections in Manitoba, Canada. Sex Transm Infect (2002) 1.43
Placement changes in long-term care: three years' experience. Am J Public Health (1984) 1.34
Epidemiology and costs associated with genital warts in Canada. Sex Transm Infect (2008) 1.28
Small-area variations and sociodemographic correlates for the incidence of Crohn's disease and ulcerative colitis. Am J Epidemiol (2001) 1.27
Risk adjustment in claims-based research: the search for efficient approaches. J Clin Epidemiol (1989) 1.27
The incidence of fracture of the proximal femur in two million Canadians from 1972 to 1984. Projections for Canada in the year 2006. Clin Orthop Relat Res (1991) 1.26
Monitoring disease burden and preventive behavior with data linkage: cervical cancer among aboriginal people in Manitoba, Canada. Am J Public Health (2000) 1.19
Perianal Crohn's disease and pregnancy: role of the mode of delivery. Am J Gastroenterol (1999) 1.19
Record linkage strategies, outpatient procedures, and administrative data. Med Care (1996) 1.12
Forecasting demand for long-term care services. Health Serv Res (1985) 1.12
Seroprevalence of Helicobacter pylori, incidence of gastric cancer, and peptic ulcer-associated hospitalizations in a Canadian Indian population. Dig Dis Sci (1999) 1.10
The relationship between inflammatory bowel disease and socioeconomic variables. Am J Gastroenterol (2001) 1.07
Incidence and prevalence of diabetes in children aged 0-14 years in Manitoba, Canada, 1985-1993. Diabetes Care (1997) 1.04
Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study. Am J Gastroenterol (2001) 1.03
Formal and informal sector health providers in southern India: role in the prevention and care of sexually transmitted infections, including HIV/AIDS. AIDS Care (2007) 1.02
Record linkage in Australian epidemiological research: health benefits, privacy safeguards and future potential. Aust J Public Health (1995) 1.00
Disparity between influenza vaccination rates and risks for influenza-associated hospital discharge and death in Manitoba in 1982-1983. Ann Intern Med (1992) 0.99
Incidence of second primary breast cancer among women with a first primary in Manitoba, Canada. Breast Cancer Res Treat (2001) 0.99
Rates and determinants of HIV-attributable mortality among rural female sex workers in Northern Karnataka, India. Int J STD AIDS (2012) 0.93
The epidemiology of Crohn's disease. Gastroenterology (1999) 0.91
Immigrant and refugee health. Emerg Infect Dis (1998) 0.86
Software for health care analysts: a modular approach. J Med Syst (1987) 0.85
Excess costs of diabetes in the Aboriginal population of Manitoba, Canada. Can J Public Health (2000) 0.85
Effects of ticlopidine, a new platelet aggregation inhibitor in man. Clin Pharmacol Ther (1975) 0.84
Phase specific approaches to the epidemiology and prevention of sexually transmitted diseases. Sex Transm Infect (2002) 0.80
Elevated serum levels of neopterin but not beta 2-microglobulin in HIV-1-seronegative injecting drug users. AIDS (1993) 0.80
Viruses and inflammatory bowel disease: is there evidence for a causal association? Inflamm Bowel Dis (2000) 0.80
Evaluation of mutagenic and antimutagenic properties of some bioactive xanthone derivatives using Vibrio harveyi test. Lett Appl Microbiol (2009) 0.79
Assessing physicians' compliance with guidelines for Papanicolaou testing. Med Care (1992) 0.79
Immigrant suicide in Australia, Canada, England and Wales, and the United States. J Aust Popul Assoc (1991) 0.77
The interactions of ticlopidine and aspirin in normal subjects. J Int Med Res (1977) 0.77
TGF-β1 gene polymorphism in renal transplant patients with and without gingival overgrowth. Oral Dis (2011) 0.75
Using administrative health data to monitor potential adverse health effects in environmental studies. Environ Res (1994) 0.75
The prescription of methadone for opiate dependence in Australia, 1985-1991. Med J Aust (1993) 0.75
Is there a role for surgery in the acute management of infective endocarditis? A decision analysis and medical claims database approach. Med Decis Making (1988) 0.75
Differences between seven measures of self-reported numbers of clients of female sex workers in southern India: implications for individual- and population-level analysis. AIDS Behav (2013) 0.75